PNC Financial Services Group’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
Other funds holding CSTL
RI
PCM
VCM
SPPAM
VPM
PNC Financial Services Group's CSTL Position: Q1 2026 in Review
PNC Financial Services Group reduced its Castle Biosciences (CSTL) stake by 70% in Q1 2026, selling an estimated $12.5K and leaving 163 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #4365.
PNC Financial Services Group first reported a position in CSTL in Q4 2020 and has held it in 19 quarters since. The position peaked at $168K in Q1 2022. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.
- PNC Financial Services Group held 163 shares of Castle Biosciences worth $4K as of Q1 2026.
- PNC Financial Services Group sold 383 Castle Biosciences shares in Q1 2026, an estimated $12.5K.
- Castle Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #4365 holding.
- PNC Financial Services Group first reported a position in Castle Biosciences in Q4 2020 and has held it in 19 quarters since.
- PNC Financial Services Group's Castle Biosciences position peaked at $168K in Q1 2022.
- 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.